Fresenius Medical Care provides an overview of the analysts’ recommendations and the consensus estimates.
In our analysis of the shareholder structure as of December 31, 2023, approximately 93% of the free float could be attributed to their respective owners. Accordingly, the largest shareholder, Fresenius SE & Co. KGaA, continues to hold approximately 94.4 M of the total approximately 293.4 M outstanding Fresenius Medical Care shares. This corresponds to a stake of 32.2%. Additionally, 13 institutional investors were identified as holding at least 1% of the share capital.
587 institutional investors hold shares of Fresenius Medical Care according to the latest analysis. The largest 20 of them account for approximately 66.0% of the identified free float, excluding the stake of Fresenius SE & Co. KGaA (previous year: 60.5%).
66.6% of the institutional free float as of December 31, 2023, was held by investors from the United States. 11.2% were from the United Kingdom. 3.8% of the institutional free float could be identified in Germany, 3.8% in France, and another 5.2% in Canada.
Number of shares in M | Number of shares in % | |
---|---|---|
Identified shares | 279.2 | 95.1% |
Unidentified shares | 14.3 | 4.9% |
Number of shares outstanding | 293.4 | 100.0% |
Identified shares in free float | 184.8 | 63.0% |
Unidentified shares in free float | 14.3 | 4.9% |
Shares in free float | 199.0 | 67.8% |
Shares in free float | 199.0 | 67.8% |
Fresenius SE & Co. KGaA | 94.4 | 32.2% |
Number of shares outstanding | 293.4 | 100.0% |